LexDanaLexDanabeta
Inventor

Tobias Welt

Inventor
Zurich, CH

Overview

2→
Patents
2019–2020
Patent span
Human necessities
Primary field (CPC A)

Patents· 2 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes20%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations20%
C07KPeptides20%
A01KAnimal husbandry10%
C12NMicroorganisms or enzymes10%
C12YEnzymes10%
G01NInvestigating or analysing materials by determining their chemical or physical properties10%
PatentTitleYear
10,544,213Compounds capable of antagonizing islet amyloid polypeptide (IAPP) induced beta-cell damage and impaired glucose tolerance202010,344,097Human anti-SOD1 antibodies2019

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2019–2020Patents assigned to NEURIMMUNE HOLDING AG (2)· patent assignee history
2019–2020Patents assigned to UNIV ZUERICH (2)· patent assignee history
2019–2020Based in Zurich, CH· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
NEURIMMUNE HOLDING AG22019–2020
UNIV ZUERICH22019–2020
Locations
LocationPatentsSpan
Zurich, CH22019–2020